All In Biotech

Drug Trial Radar · NCT05906862

AMT-253 in Patients With Selected Advanced Solid Tumours

First-in-Human, Phase 1 Study of AMT-253, in Patients With Advanced Solid Tumors

Last checked: Nov 19, 2026Latest source record: Aug 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

54

Planned (sponsor's estimate)

Start

Nov 6, 2023

Primary completion

Sep 30, 2026

Study completion Dec 30, 2026

Sponsor

Sponsor type
Industry
First posted
Jun 18, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This first-in-human study will evaluate the Maximum Tolerated Dose (MTD) / the Recommended Phase 2 Dose (RP2D), safety, tolerability, anti-tumor activity, pharmacokinetics, pharmacodynamics and immunogenicity of AMT-253, in Patients with Advanced Solid Tumors

Conditions

  • Advanced Solid Tumor

Interventions

  • AMT-253Drug

    Administered intravenously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Recommended Phase 2 Dose (RP2D)Time frame: Up to 24 months
  2. Maximum Tolerated Dose (MTD)Time frame: Up to 24 months
  3. Type, incidence and severity of Adverse EventsTime frame: Up to 24 months

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Blacktown

    Sydney, New South Wales, Australia · Recruiting

  • Chris O'Brien Lifehouse

    Sydney, New South Wales, Australia · Recruiting

  • Maquarie University Hospital

    Sydney, New South Wales, Australia · Recruiting

  • ICON Cancer Centre

    Brisbane, Queensland, Australia · Recruiting

  • Southern Oncology Clinical Research

    Adelaide, South Australia, Australia · Recruiting

  • Cabrini Malvern Hospital

    Malvern, Victoria, Australia · Recruiting

  • Alfred Hospital

    Melbourne, Victoria, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.